类风湿关节炎患者-话题@MedSci - 梅斯（MedSci）

#类风湿关节炎患者#

75篇内容 | 2184人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1803978, encodeId=9d4918039e856, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低, objectType=article, longId=202101, objectId=906420210148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=906420210148, replyNumber=0, likeNumber=85, createdTime=2021-05-14, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=906420210148, moduleTitle=Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=906420210148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803979, encodeId=26fd18039e992, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Nat Commun：花生四烯酸调节类风湿关节炎患者T细胞的钙信号传导促进滑膜炎的发生, objectType=article, longId=207304, objectId=cee520e30428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cee520e30428, replyNumber=0, likeNumber=75, createdTime=2021-06-10, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cee520e30428, moduleTitle=Nat Commun：花生四烯酸调节类风湿关节炎患者T细胞的钙信号传导促进滑膜炎的发生, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cee520e30428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803974, encodeId=336218039e4a9, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=J INTERN MED：类风湿关节炎患者睡眠障碍与血管反应性, objectType=article, longId=193023, objectId=030619302365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=030619302365, replyNumber=0, likeNumber=93, createdTime=2020-08-24, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=030619302365, moduleTitle=J INTERN MED：类风湿关节炎患者睡眠障碍与血管反应性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=030619302365)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803976, encodeId=0d5418039e66d, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=中国类风湿关节炎患者的福音！阿达木单抗生物类似物SULINNO在中国获准上市, objectType=article, longId=200229, objectId=e99e20022968, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e99e20022968, replyNumber=0, likeNumber=115, createdTime=2021-06-26, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e99e20022968, moduleTitle=中国类风湿关节炎患者的福音！阿达木单抗生物类似物SULINNO在中国获准上市, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e99e20022968)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803975, encodeId=1f8218039e52c, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Lancet：维持低剂量糖皮质激素治疗对低疾病活动度的类风湿关节炎患者症状控制更为有效, objectType=article, longId=198030, objectId=5ec3198030cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ec3198030cb, replyNumber=0, likeNumber=91, createdTime=2021-03-21, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ec3198030cb, moduleTitle=Lancet：维持低剂量糖皮质激素治疗对低疾病活动度的类风湿关节炎患者症状控制更为有效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5ec3198030cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803972, encodeId=b93c18039e29a, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Heart：早期类风湿关节炎患者的心血管危险因素和结局, objectType=article, longId=190823, objectId=50c31908235a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50c31908235a, replyNumber=0, likeNumber=94, createdTime=2021-01-16, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50c31908235a, moduleTitle=Heart：早期类风湿关节炎患者的心血管危险因素和结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=50c31908235a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803977, encodeId=172b18039e77f, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险, objectType=article, longId=201337, objectId=860520133e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=860520133e20, replyNumber=0, likeNumber=94, createdTime=2021-08-12, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=860520133e20, moduleTitle=Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=860520133e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803971, encodeId=934218039e18a, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=NEJM：类风湿关节炎患者的伸缩式手指-病例报道, objectType=article, longId=184642, objectId=020118464243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=020118464243, replyNumber=0, likeNumber=60, createdTime=2020-01-11, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=020118464243, moduleTitle=NEJM：类风湿关节炎患者的伸缩式手指-病例报道, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=020118464243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803973, encodeId=35c618039e35d, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Radiology：跖趾关节周围肌腱有腱鞘包裹吗？其在类风湿关节炎患者中的跖趾关节MRI表现是怎样的？, objectType=article, longId=192319, objectId=b91719231929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b91719231929, replyNumber=0, likeNumber=78, createdTime=2020-08-03, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b91719231929, moduleTitle=Radiology：跖趾关节周围肌腱有腱鞘包裹吗？其在类风湿关节炎患者中的跖趾关节MRI表现是怎样的？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b91719231929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803970, encodeId=962718039e08b, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Rheumatology (Oxford)：多大比例的类风湿关节炎患者使用利妥昔单抗4年以上？, objectType=article, longId=141358, objectId=88ef1413581a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ef1413581a, replyNumber=0, likeNumber=63, createdTime=2018-11-17, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ef1413581a, moduleTitle=Rheumatology (Oxford)：多大比例的类风湿关节炎患者使用利妥昔单抗4年以上？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=88ef1413581a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803965, encodeId=828d1803965c4, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=激素在类风湿关节炎患者中的使用异议, objectType=article, longId=128417, objectId=8c4912841e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c4912841e2a, replyNumber=0, likeNumber=82, createdTime=2018-09-21, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c4912841e2a, moduleTitle=激素在类风湿关节炎患者中的使用异议, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8c4912841e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803963, encodeId=33591803963b5, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Ann Rheum Dis： LBEC0101和依那西普对甲氨蝶呤反应不良性活动类风湿关节炎患者疗效和安全性的III期研究, objectType=article, longId=124092, objectId=25b012409255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25b012409255, replyNumber=0, likeNumber=163, createdTime=2018-10-07, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25b012409255, moduleTitle=Ann Rheum Dis： LBEC0101和依那西普对甲氨蝶呤反应不良性活动类风湿关节炎患者疗效和安全性的III期研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=25b012409255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803969, encodeId=774218039693c, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, objectType=article, longId=140780, objectId=68e0140e800a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68e0140e800a, replyNumber=0, likeNumber=73, createdTime=2018-08-29, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68e0140e800a, moduleTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=68e0140e800a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803967, encodeId=0c64180396e57, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=中国类风湿关节炎患者报告的临床结局量表专家共识, objectType=article, longId=139189, objectId=1d791391894a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d791391894a, replyNumber=0, likeNumber=68, createdTime=2019-05-02, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d791391894a, moduleTitle=中国类风湿关节炎患者报告的临床结局量表专家共识, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1d791391894a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803966, encodeId=01b7180396699, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Med J Islam Repub Iran：类风湿关节炎患者的牙周炎情况如何, objectType=article, longId=131371, objectId=b2011313e155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2011313e155, replyNumber=0, likeNumber=51, createdTime=2018-05-15, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2011313e155, moduleTitle=Med J Islam Repub Iran：类风湿关节炎患者的牙周炎情况如何, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b2011313e155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803968, encodeId=9afb1803968fb, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=J Periodontol: 类风湿关节炎患者使用免疫抑制剂后的牙周状况, objectType=article, longId=139289, objectId=0ac3139289dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ac3139289dc, replyNumber=0, likeNumber=79, createdTime=2019-01-04, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ac3139289dc, moduleTitle=J Periodontol: 类风湿关节炎患者使用免疫抑制剂后的牙周状况, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ac3139289dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803964, encodeId=05bc18039641d, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Ann Rheum Dis：类风湿关节炎患者ACS的复发和死亡风险高于普通人群？, objectType=article, longId=124966, objectId=4a441249665c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a441249665c, replyNumber=0, likeNumber=63, createdTime=2018-04-02, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a441249665c, moduleTitle=Ann Rheum Dis：类风湿关节炎患者ACS的复发和死亡风险高于普通人群？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4a441249665c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803957, encodeId=ba3e180395e5d, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Arthritis Rheumatol:美国类风湿关节炎患者阿片类药物使用趋势变化, objectType=article, longId=114136, objectId=53c311413694, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53c311413694, replyNumber=0, likeNumber=70, createdTime=2018-03-12, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53c311413694, moduleTitle=Arthritis Rheumatol:美国类风湿关节炎患者阿片类药物使用趋势变化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=53c311413694)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803961, encodeId=516c18039618f, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=Ann Rheum Dis：糖皮质激素在早期类风湿关节炎患者中的耐受性如何？, objectType=article, longId=121684, objectId=d94e121684a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d94e121684a4, replyNumber=0, likeNumber=63, createdTime=2018-03-10, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d94e121684a4, moduleTitle=Ann Rheum Dis：糖皮质激素在早期类风湿关节炎患者中的耐受性如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d94e121684a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803956, encodeId=f13c1803956aa, content=<a href='/topic/show?id=62c7e6169ed' target=_blank style='color:#2F92EE;'>#类风湿关节炎患者#</a>, objectTitle=JAMA Intern Med：类风湿关节炎患者接受生物单抗治疗后肿瘤风险研究, objectType=article, longId=114131, objectId=83ef1141317a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ef1141317a, replyNumber=0, likeNumber=65, createdTime=2018-02-20, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ef1141317a, moduleTitle=JAMA Intern Med：类风湿关节炎患者接受生物单抗治疗后肿瘤风险研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=83ef1141317a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

类风湿关节炎患者

2020-05-29

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低

2021-05-14

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Nat Commun：花生四烯酸调节类风湿关节炎患者T细胞的钙信号传导促进滑膜炎的发生

2021-06-10

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

J INTERN MED：类风湿关节炎患者睡眠障碍与血管反应性

2020-08-24

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

中国类风湿关节炎患者的福音！阿达木单抗生物类似物SULINNO在中国获准上市

2021-06-26

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Lancet：维持低剂量糖皮质激素治疗对低疾病活动度的类风湿关节炎患者症状控制更为有效

2021-03-21

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Heart：早期类风湿关节炎患者的心血管危险因素和结局

2021-01-16

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险

2021-08-12

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

NEJM：类风湿关节炎患者的伸缩式手指-病例报道

2020-01-11

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Radiology：跖趾关节周围肌腱有腱鞘包裹吗？其在类风湿关节炎患者中的跖趾关节MRI表现是怎样的？

2020-08-03

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Rheumatology (Oxford)：多大比例的类风湿关节炎患者使用利妥昔单抗4年以上？

2018-11-17

智者为医08 (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

激素在类风湿关节炎患者中的使用异议

2018-09-21

智者为医08 (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Ann Rheum Dis： LBEC0101和依那西普对甲氨蝶呤反应不良性活动类风湿关节炎患者疗效和安全性的III期研究

2018-10-07

智者为医08 (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状

2018-08-29

智者为医08 (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

中国类风湿关节炎患者报告的临床结局量表专家共识

2019-05-02

智者为医08 (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Med J Islam Repub Iran：类风湿关节炎患者的牙周炎情况如何

2018-05-15

智者为医08 (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

J Periodontol: 类风湿关节炎患者使用免疫抑制剂后的牙周状况

2019-01-04

智者为医08 (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Ann Rheum Dis：类风湿关节炎患者ACS的复发和死亡风险高于普通人群？

2018-04-02

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Arthritis Rheumatol:美国类风湿关节炎患者阿片类药物使用趋势变化

2018-03-12

智者为医08 (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

Ann Rheum Dis：糖皮质激素在早期类风湿关节炎患者中的耐受性如何？

2018-03-10

shenxlcyp (审核中...)

前往app查看评论内容

#类风湿关节炎患者#

JAMA Intern Med：类风湿关节炎患者接受生物单抗治疗后肿瘤风险研究

2018-02-20

科室
- - 订阅+
  - 更多科室
工具
服务